お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は非ステロイド系抗炎症剤市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは非ステロイド系抗炎症剤の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の非ステロイド系抗炎症剤市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは非ステロイド系抗炎症剤のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に非ステロイド系抗炎症剤市場を分類しています。本研究に含まれる主な企業は：Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Allergan、Purdue

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Ibuprofen
    Naproxen

用途別の市場セグメント：
    Hospitals
    Clinics
    Drugstores

本レポートの詳細内容
世界の非ステロイド系抗炎症剤市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、非ステロイド系抗炎症剤タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の非ステロイド系抗炎症剤収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の非ステロイド系抗炎症剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、非ステロイド系抗炎症剤市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

非ステロイド系抗炎症剤のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：非ステロイド系抗炎症剤のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：非ステロイド系抗炎症剤の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章非ステロイド系抗炎症剤企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：非ステロイド系抗炎症剤の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：非ステロイド系抗炎症剤の主要企業の概要を提供し、製品の説明と仕様、非ステロイド系抗炎症剤の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global NSAIDs Drug Market
The global NSAIDs Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for NSAIDs Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of NSAIDs Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NSAIDs Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the NSAIDs Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global NSAIDs Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for NSAIDs Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc.

Market Segmentation
By Company
    Pfizer
    GSK
    Grunenthal
    Bayer
    Sanofi
    Eli Lilly
    AstraZeneca
    Endo
    Merck
    Depomed
    Yunnan Baiyao
    Teva
    J&J
    Allergan
    Purdue

Segment by Type
    Ibuprofen
    Naproxen

Segment by Application
    Hospitals
    Clinics
    Drugstores

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of NSAIDs Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NSAIDs Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NSAIDs Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global NSAIDs Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Ibuprofen
    Table 3. Key Players of Naproxen
    Table 4. Global NSAIDs Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global NSAIDs Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global NSAIDs Drug Market Share by Region (2019-2024)
    Table 8. Global NSAIDs Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global NSAIDs Drug Market Share by Region (2025-2030)
    Table 10. NSAIDs Drug Market Trends
    Table 11. NSAIDs Drug Market Drivers
    Table 12. NSAIDs Drug Market Challenges
    Table 13. NSAIDs Drug Market Restraints
    Table 14. Global NSAIDs Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global NSAIDs Drug Revenue Share by Players (2019-2024)
    Table 16. Global Top NSAIDs Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2023)
    Table 17. Global NSAIDs Drug Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by NSAIDs Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of NSAIDs Drug, Headquarters and Area Served
    Table 20. Global Key Players of NSAIDs Drug, Product and Application
    Table 21. Global Key Players of NSAIDs Drug, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global NSAIDs Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global NSAIDs Drug Revenue Market Share by Type (2019-2024)
    Table 25. Global NSAIDs Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global NSAIDs Drug Revenue Market Share by Type (2025-2030)
    Table 27. Global NSAIDs Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global NSAIDs Drug Revenue Share by Application (2019-2024)
    Table 29. Global NSAIDs Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global NSAIDs Drug Revenue Share by Application (2025-2030)
    Table 31. North America NSAIDs Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America NSAIDs Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America NSAIDs Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America NSAIDs Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America NSAIDs Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America NSAIDs Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America NSAIDs Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe NSAIDs Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe NSAIDs Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe NSAIDs Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe NSAIDs Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe NSAIDs Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe NSAIDs Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe NSAIDs Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China NSAIDs Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China NSAIDs Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China NSAIDs Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China NSAIDs Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia NSAIDs Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia NSAIDs Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia NSAIDs Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia NSAIDs Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia NSAIDs Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia NSAIDs Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia NSAIDs Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America NSAIDs Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America NSAIDs Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America NSAIDs Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America NSAIDs Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America NSAIDs Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America NSAIDs Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America NSAIDs Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer NSAIDs Drug Product
    Table 66. Pfizer Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. GSK Company Details
    Table 69. GSK Business Overview
    Table 70. GSK NSAIDs Drug Product
    Table 71. GSK Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 72. GSK Recent Developments
    Table 73. Grunenthal Company Details
    Table 74. Grunenthal Business Overview
    Table 75. Grunenthal NSAIDs Drug Product
    Table 76. Grunenthal Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 77. Grunenthal Recent Developments
    Table 78. Bayer Company Details
    Table 79. Bayer Business Overview
    Table 80. Bayer NSAIDs Drug Product
    Table 81. Bayer Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 82. Bayer Recent Developments
    Table 83. Sanofi Company Details
    Table 84. Sanofi Business Overview
    Table 85. Sanofi NSAIDs Drug Product
    Table 86. Sanofi Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 87. Sanofi Recent Developments
    Table 88. Eli Lilly Company Details
    Table 89. Eli Lilly Business Overview
    Table 90. Eli Lilly NSAIDs Drug Product
    Table 91. Eli Lilly Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 92. Eli Lilly Recent Developments
    Table 93. AstraZeneca Company Details
    Table 94. AstraZeneca Business Overview
    Table 95. AstraZeneca NSAIDs Drug Product
    Table 96. AstraZeneca Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 97. AstraZeneca Recent Developments
    Table 98. Endo Company Details
    Table 99. Endo Business Overview
    Table 100. Endo NSAIDs Drug Product
    Table 101. Endo Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 102. Endo Recent Developments
    Table 103. Merck Company Details
    Table 104. Merck Business Overview
    Table 105. Merck NSAIDs Drug Product
    Table 106. Merck Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 107. Merck Recent Developments
    Table 108. Depomed Company Details
    Table 109. Depomed Business Overview
    Table 110. Depomed NSAIDs Drug Product
    Table 111. Depomed Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 112. Depomed Recent Developments
    Table 113. Yunnan Baiyao Company Details
    Table 114. Yunnan Baiyao Business Overview
    Table 115. Yunnan Baiyao NSAIDs Drug Product
    Table 116. Yunnan Baiyao Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 117. Yunnan Baiyao Recent Developments
    Table 118. Teva Company Details
    Table 119. Teva Business Overview
    Table 120. Teva NSAIDs Drug Product
    Table 121. Teva Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 122. Teva Recent Developments
    Table 123. J&J Company Details
    Table 124. J&J Business Overview
    Table 125. J&J NSAIDs Drug Product
    Table 126. J&J Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 127. J&J Recent Developments
    Table 128. Allergan Company Details
    Table 129. Allergan Business Overview
    Table 130. Allergan NSAIDs Drug Product
    Table 131. Allergan Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 132. Allergan Recent Developments
    Table 133. Purdue Company Details
    Table 134. Purdue Business Overview
    Table 135. Purdue NSAIDs Drug Product
    Table 136. Purdue Revenue in NSAIDs Drug Business (2019-2024) & (US$ Million)
    Table 137. Purdue Recent Developments
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NSAIDs Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global NSAIDs Drug Market Share by Type: 2023 VS 2030
    Figure 3. Ibuprofen Features
    Figure 4. Naproxen Features
    Figure 5. Global NSAIDs Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global NSAIDs Drug Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Drugstores Case Studies
    Figure 10. NSAIDs Drug Report Years Considered
    Figure 11. Global NSAIDs Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global NSAIDs Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global NSAIDs Drug Market Share by Region: 2023 VS 2030
    Figure 14. Global NSAIDs Drug Market Share by Players in 2023
    Figure 15. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by NSAIDs Drug Revenue in 2023
    Figure 17. North America NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America NSAIDs Drug Market Share by Type (2019-2030)
    Figure 19. North America NSAIDs Drug Market Share by Application (2019-2030)
    Figure 20. North America NSAIDs Drug Market Share by Country (2019-2030)
    Figure 21. United States NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe NSAIDs Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe NSAIDs Drug Market Share by Type (2019-2030)
    Figure 25. Europe NSAIDs Drug Market Share by Application (2019-2030)
    Figure 26. Europe NSAIDs Drug Market Share by Country (2019-2030)
    Figure 27. Germany NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China NSAIDs Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China NSAIDs Drug Market Share by Type (2019-2030)
    Figure 35. China NSAIDs Drug Market Share by Application (2019-2030)
    Figure 36. Asia NSAIDs Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia NSAIDs Drug Market Share by Type (2019-2030)
    Figure 38. Asia NSAIDs Drug Market Share by Application (2019-2030)
    Figure 39. Asia NSAIDs Drug Market Share by Region (2019-2030)
    Figure 40. Japan NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America NSAIDs Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America NSAIDs Drug Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America NSAIDs Drug Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America NSAIDs Drug Market Share by Country (2019-2030)
    Figure 50. Brazil NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries NSAIDs Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 57. GSK Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 58. Grunenthal Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 59. Bayer Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 60. Sanofi Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 61. Eli Lilly Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 62. AstraZeneca Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 63. Endo Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 65. Depomed Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 66. Yunnan Baiyao Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 67. Teva Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 68. J&J Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 69. Allergan Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 70. Purdue Revenue Growth Rate in NSAIDs Drug Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed